Programmable Tumor‐Activated NanoCRISPR Platform Synergizes cGAS‐STING Activation With PD‐L1 Blockade for Potentiated Antitumor Immunity
Year: 2026
Type: article
Source: Advanced Functional Materials
DOI: 10.1002/adfm.76550
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W7165017448
